Ted William Karkus
Net Worth

Last updated:

What is Ted William Karkus net worth?

The estimated net worth of Mr. Ted William Karkus is at least $6,965,043 as of 1 Feb 2023. He owns shares worth $735,043 as insider and has received compensation worth at least $6,230,000 in ProPhase Labs, Inc..

What is the salary of Ted William Karkus?

Mr. Ted William Karkus salary is $445,000 per year as Chairman & Chief Executive Officer in ProPhase Labs, Inc..

How old is Ted William Karkus?

Mr. Ted William Karkus is 66 years old, born in 1959.

What stocks does Ted William Karkus currently own?

As insider, Mr. Ted William Karkus owns shares in one company:

Company Title Shares Price per share Total value
ProPhase Labs, Inc. (PRPH) Chairman & Chief Executive Officer 2,333,471 $0.32 $735,043

What does ProPhase Labs, Inc. do?

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

PRPH logo
PRPH
ProPhase Labs, Inc.
$0.32

Ted William Karkus insider trading

ProPhase Labs, Inc.

Mr. Ted William Karkus has made 4 insider trades between 2011-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 600,000 units of PRPH stock on 14 Dec 2017. As of 1 Feb 2023 he still owns at least 2,333,471 units of PRPH stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock, par value $0.005 500,000 $0.6 $300,000
Option
Option (right to buy) 500,000 $0.6 $300,000
Option
Option (right to buy) 600,000 $0.6 $360,000
Option
Common Stock, par value $0.005 600,000 $0.6 $360,000
Option
Common Stock, par value $0.005 600,000 $0.6 $360,000
Option
Option (right to buy) 600,000 $0.6 $360,000
Option
Common Stock, par value $0.005 600,000 $0.6 $360,000
Option
Option (right to buy) 600,000 $0.6 $360,000
Option
Option (right to buy) 450,000 $2 $900,000
Option
Common Stock, par value $0.005 450,000 $2 $900,000
Purchase
Common Stock, par value $0.005 33,943 N/A N/A
Sale
Common Stock, par value $0.005 50,000 N/A N/A
Sale
Common Stock, par value $0.005 100,000 N/A N/A
Option
Employee Stock Option (right to buy) 250,000 N/A N/A
Option
Common Stock, par value $0.005 250,000 N/A N/A
Option
Common Stock, par value $0.005 250,000 N/A N/A
Option
Employee Stock Option (right to buy) 250,000 N/A N/A
Sale
Common Stock, par value $0.005 424,789 N/A N/A
Option
Common Stock, par value $0.005 600,000 N/A N/A
Option
Employee Stock Option (right to buy) 600,000 N/A N/A
Sale
Common Stock, par value $0.005 364,950 N/A N/A
Purchase
Common Stock, par value $0.0005 200,000 N/A N/A
Purchase
Common Stock, par value $0.0005 199,504 N/A N/A
Purchase
Common Stock, par value $0.0005 10,496 N/A N/A
Purchase
Common Stock, par value $0.0005 155,480 N/A N/A
Purchase
Common Stock, par value $0.0005 286,150 N/A N/A
Purchase
Common Stock, par value $0.0005 58,370 N/A N/A
Purchase
Common Stock, par value $0.0005 103,402 N/A N/A
Purchase
Common Stock, par value $0.0005 141,388 N/A N/A
Purchase
Common Stock, par value $0.0005 19,192 N/A N/A
Purchase
Common Stock, par value $0.0005 171,018 N/A N/A

ProPhase Labs key executives

ProPhase Labs, Inc. executives and other stock owners filed with the SEC: